Clinical Trial Update: M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated M7824 (bintrafusp alfa) in patients with stage II-III HER2-positive breast cancer and various AJCC stage groupings; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• M7824 (bintrafusp alfa)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 | Phase 1 | Status: COMPLETED